Claybrook Capital, LLC Johnson & Johnson Transaction History

Claybrook Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	BUY	$155.93 - $173.01 $24,013 - $26,643	154 Added 9.17%	1,834 $314,000
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $7.08 Million - $7.87 Million	-43,825 Reduced 96.31%	1,680 $271,000
Q2 2021 Jul 26, 2021	BUY	$159.48 - $171.07 $6.99 Million - $7.5 Million	43,825 Added 2608.63%	45,505 $7.5 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $1.17 Million - $1.3 Million	-9,323 Reduced 84.73%	1,680 $235,000
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $1.15 Million - $1.38 Million	9,323 Added 554.94%	11,003 $1.42 Million
Q4 2017 May 08, 2018	BUY	$131.22 - $143.62 $220,449 - $241,281	1,680	1,680 $235,000

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Claybrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Claybrook Capital, LLC with notifications on news.